Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

NCT01008150 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

141

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Trastuzumab
DRUG: Neratinib
DRUG: Doxorubicin
DRUG: Cyclophosphamide

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]